Biendl S, Häberli C, Keiser J. Discovery of novel antischistosomal scaffolds from the open access Pandemic Response Box. Expert Rev Anti Infect Ther. 2022;20(4):621-629. DOI: 10.1080/14787210.2022.1990042

2022
Journal Article
PubMed

Probst A, Biendl S, Keiser J. Improving translational power in antischistosomal drug discovery. Adv Parasitol. 2022;117:47-73. DOI: 10.1016/bs.apar.2022.05.002

2022
Journal Article
PubMed

Ravaynia P.S, Biendl S, Grassi F, Keiser J, Hierlemann A, Modena M.M. Real-time and automated monitoring of antischistosomal drug activity profiles for screening of compound libraries. iScience. 2022;25(4):104087. DOI: 10.1016/j.isci.2022.104087

2022
Journal Article
PubMed

Ravaynia P.S, Lombardo F.C, Biendl S, Dupuch M.A, Keiser J, Hierlemann A, Modena M.M. Parallelized impedance-based platform for continuous dose-response characterization of antischistosomal drugs. Adv Biosyst. 2020;4(7):e1900304. DOI: 10.1002/adbi.201900304

2020
Journal Article
PubMed